Biotechnology Transfer & Commercialization Conference
Conference - Philadelphia, PA, US
Leading innovations in biotech advancement and discovery are found within academic institutions and emerging companies. These organizations play an increasingly important role, both in the U.S. and around the world, in developing new drug therapies for the treatment of diseases ranging from Alzheimer’s to cancer to Cystic Fibrosis to HIV/AIDS and many others. Their role in researching new therapies is instrumental in developing the next phase of disease treatment.
GTC’s Biotechnology Transfer & Commercialization Conference will bring together the players needed to move the industry forward. Leading universities, pharmaceutical companies, venture capital, foundations and biotech companies will come together to share their perspectives, discuss new models of cooperation and develop the business relationships that get deals done. Together they will create new technologies, new companies and new medicines.
This Conference is part of the 8th Modern Drug Discovery and Development Summit. Other conference tracks include:
9th Stem Cell Research and Therapeutics Conference
7th Assay and Drug Discovery Technologies Conference
4th Translational Medicine Conference
3rd Pharmacokinetics and Pharmacodynamics Conference
http://www.gtcbio.com/component/conference
Wednesday, October 24, 2012 to Friday, October 26, 2012
Pennsylvania Convention Center
100 Level 12th and Arch Street, Philadelphia, PA 19107
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
